COPsync Announces $1.1 Million Registered Direct Offering

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
42
COPsync Announces $1.1 Million Registered Direct Offering of Common Stock

DALLAS, TX--(Marketwired - Feb 15, 2017) - COPsync, Inc. ( NASDAQ : COYN ) today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase an aggregate of 1,958,000 shares of common stock in a registered direct offering. In a concurrent private placement, the Company has agreed to sell to the same investors warrants to purchase 1,958,000 shares of its common stock. The combined purchase price for one registered share of common stock and one warrant is $0.57. The warrants will have an exercise price of $0.46 and will be exercisable beginning on the six-month anniversary following the closing of the private placement and will expire on the five-year anniversary of the date on which they become exercisable.

The aggregate gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $1.1 million before deducting the placement agent's fee and other estimated offering expenses. The registered direct offering and concurrent private placement are expected to close on or about February 21, 2017, subject to customary closing conditions.

The Company intends to use the aggregate net proceeds from the registered direct offering and concurrent private placement for expansion of sales and marketing, working capital, continued product development and network enhancement, and other corporate purposes.

Maxim Group LLC is acting as the lead placement agent for the registered direct offering and the concurrent private placement.

The shares of common stock described above are being offered by COPsync pursuant to a "shelf" registration statement on Form S-3 (File No. 333-212389) filed with the Securities and Exchange Commission (the "SEC"), which was declared effective on July 13, 2016. A prospectus supplement relating to the shares of common stock will be filed by the Company with the SEC.

When available, copies of the prospectus supplement, together with the accompanying base prospectus, can be obtained at the SEC's website at www.sec.gov or from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174 or via telephone at 212-895-3745.

The warrants and shares of the Company's common stock issuable upon exercise of the warrants have not been registered with the SEC and are being offered in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended.

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About COPsync, Inc.

COPsync, Inc. ( NASDAQ : COYN ) is a technology company that connects law enforcement officers across the nation, so they can communicate and share mission-critical information in real-time. This saves officers' lives and keeps the public safer, helps law enforcement officers catch common criminals and stop child kidnappings, vehicle thefts, bank robberies and other crimes in progress, and arms the nation's law enforcement officers with needed information so they can help defend against terrorism. For more information, go to www.copsync.com .

Safe Harbor Statement

Statements in this press release that are not purely historical facts or that depend upon future events, including statements about forecasts of earnings, revenue, product development, sales, proposed financing transactions or other statements about anticipations, beliefs, expectations, intentions, plans or strategies for the future, may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. For example, statements containing words like "expect," "anticipate," "potential," "expects," "believe," "confident," "estimated," "future," "plan," "planning," "projected," "strategy," "pursuing," "objective" and other similar terms, express management's current views concerning future events, trends, contingencies or results, which may be considered forward-looking statements. Specifically, the statement "The Company intends to use the aggregate net proceeds from the registered direct offering and concurrent private placement for . . . ." Readers are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements are based on information available to the Company on the date this release was issued. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Any forward-looking statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks or uncertainties related to the Company's ability to succeed in its sales strategy, raise sufficient capital, meet its debt obligations as they become due, maintain its NASDAQ listing or succeed in its business strategy, which may adversely affect the Company's business and the value of an investment in the Company's stock. The Company may not succeed in adequately addressing and managing these and other risks. Further information regarding factors that could affect the Company's financial, operating and other results can be found in the risk factors section of the Company's registration statement filed with the Securities and Exchange Commission.

Contact: Investor Relations Everest Corporate Advisors, Inc. 702-902-2361 702-982-1339 For COPsync: Ronald A. Woessner Chief Executive Officer 972-865-6192 invest@copsync.com Media: Cynthia Vetter Director of Media and Investor Relations cvetter@copsync.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 203

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 346

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 209

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 181

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 232

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 319

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 407

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Growth of Electronic Trial Master File Market Explained

Updated Category News Views 150

Overview of the Electronic Trial Master File Market The Electronic Trial Master File (eTMF) market is set for impressive growth, projected to reach USD 2.8 billion in the coming years. This rise is being fueled by the increasing demand for integrated eTMF systems and the growing number of clinical trials. As clinical trials become more complex and far-reaching, the...

Continue Reading
Understanding July 2025 Beer Taxable Removals Trends

Updated Category News Views 213

Insights into July 2025 Beer Taxable Removals As we look at the activities in the brewing industry, a significant detail emerged regarding the taxable removals of beer for the month of July 2025. This estimate stands at 12,625,000 barrels, reflecting a modest decrease of 0.8% from the previously recorded 12,724,742 barrels in July 2024. Such figures provide a crucial...

Continue Reading
Exciting Developments in Nutrition Share Global Insights

Updated Category News Views 131

Innovations in Nutrition at the American Society's Annual Meeting The world of food and nutrition is about to witness a significant gathering where groundbreaking discoveries will be shared at the American Society for Nutrition's flagship annual event. Nutrition professionals from various backgrounds and regions will convene to exchange insights and research findings that...

Continue Reading
Meta's Bold Plan: Reviving Stablecoins by End of 2026

Updated Category News Views 305

Of Faded Dreams and New Roads Years back, I watched as Meta tripped over itself trying to launch the Libra project. What a train wreck! That was supposed to be the golden ticket for digital payments. Now, it’s back at it like a dog chasing its tail, with plans to revive stablecoins by the end of 2026 through a partnership with third-party vendors. Feels like we’re...

Continue Reading
Leadership Changes at ICANN: New Appointments for 2025

Updated Category News Views 520

ICANN Leadership Announcement The Internet Corporation for Assigned Names and Numbers (ICANN) has shared exciting news about its leadership. Tripti Sinha has been reappointed as the Chair of the ICANN Board of Directors, and Sajid Rahman has taken the role of Vice Chair. This announcement marks a significant transition for the organization, promising new strategies and...

Continue Reading